Lufax Announces Leadership Changes and New Board Appointments
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 17 2026
0mins
Should l Buy LU?
Source: PRnewswire
- Executive Transition: Lufax's CEO Yong Suk Cho will resign on March 31, 2026, due to personal reasons, with current Co-CEO Xiang Ji appointed as the new CEO, ensuring a smooth leadership transition that is expected to enhance market stability.
- New Board Members: Yonglin Xie and Xin Fu will resign from their non-executive director roles on February 17, 2026, with Fangfang Cai and Peifeng Li appointed as new non-executive directors, potentially improving board diversity and governance standards.
- Background of New Directors: Fangfang Cai brings over 15 years of experience in the financial sector, having held various senior roles at Ping An Group, while Peifeng Li has extensive management experience in finance, which will strengthen Lufax's financial management and strategic execution capabilities.
- Strategic Implications: The leadership changes and new appointments reflect Lufax's commitment to strong leadership, aiming to drive continued growth and innovation in the competitive financial services market by introducing experienced new members.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LU
About LU
LUFAX HOLDING LTD is a holding company mainly engaged in providing financial services for small and micro enterprises. The Company's core retail credit enablement business includes bank-funded loans, trust-funded loans and consumer finance loans. The Company is also engaged in wealth management and providing access to financial products and services. The Company conducts the business through its subsidiaries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Lufax Faces Class Action Lawsuit Amid Significant Stock Drop
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Lufax, alleging securities fraud and other unlawful business practices by the company and certain officers, with investors urged to apply as Lead Plaintiff by May 20, 2026, highlighting serious governance concerns.
- Auditor Change Controversy: On January 27, 2025, Lufax proposed to replace its auditor, PricewaterhouseCoopers, due to significant concerns regarding the financial disclosures in its 2022 and 2023 Annual Reports, indicating a crisis in the company's financial transparency.
- Stock Price Volatility: Following the auditor change announcement, Lufax's American Depositary Shares fell nearly 22% over three trading sessions, a drastic decline that not only undermines investor confidence but may also negatively impact the company's future financing capabilities.
- Law Firm's Reputation: Pomerantz LLP is a prominent securities class action law firm with over 85 years of experience, focusing on advocating for victims of securities fraud, and its successful track record underscores its expertise and influence in the field.
See More
Reminder of Lufax Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they must apply to be lead plaintiff by May 20, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the truth emerged, which negatively impacted the company's reputation and investor confidence.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, demonstrating its expertise and successful track record, thereby enhancing investor trust.
- Participation Instructions: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, ensuring they select qualified legal counsel to effectively protect their rights.
See More
Faruqi & Faruqi Investigates Potential Claims Against Lufax
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Lufax Holding Ltd., particularly for investors who purchased or acquired securities between April 7, 2023, and January 26, 2025.
- Investor Rights Reminder: The firm reminds investors that May 20, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, highlighting the urgency and potential legal ramifications of the case.
- Direct Contact Channels: Investors who have suffered losses are encouraged to contact Josh Wilson, a partner at Faruq & Faruqi, directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for consultation.
- Impact of Legal Action: This investigation may negatively affect Lufax's stock price and investor confidence, especially as the company faces a class action lawsuit, potentially leading to greater legal and financial risks.
See More
Lufax Securities Fraud Class Action Reminder
- Class Action Notice: Lufax (NYSE: LU) investors are reminded of an upcoming securities fraud class action lawsuit concerning shares purchased between April 7, 2023, and January 26, 2025, urging those who suffered losses during this period to take note of the impending legal action.
- Lawsuit Details: Filed in the U.S. District Court for the Central District of California, the lawsuit alleges that Lufax and certain senior officers violated the Securities Exchange Act of 1934, claiming that misrepresentations regarding the company's internal controls led to materially misstated financial results, potentially impacting investor recovery rights.
- Lead Plaintiff Requirements: Investors wishing to serve as lead plaintiffs must file necessary documents by May 20, 2026, with the lead plaintiff representing other class members in directing the litigation, while those opting not to participate can still share in any potential recovery.
- Legal Fee Structure: All representation is on a contingency fee basis, meaning shareholders incur no fees or expenses, which reduces the financial burden on investors and encourages more affected shareholders to take action.
See More
Multiple Companies Facing Class Action Lawsuits
- Class Action Overview: Gemini Space Station, Inc., Power Solutions International, Inc., Hercules Capital, Inc., and Lufax Holding Ltd. are all facing class action lawsuits from investors, emphasizing the urgency for investors to file lead plaintiff motions by the specified deadlines.
- Gemini Lawsuit Details: The lawsuit against Gemini alleges that from September 2025 to February 2026, the company overstated the viability of its core business as a crypto platform, leading to a significant overestimation of its post-IPO financial prospects and exposing it to potential costly and disruptive restructuring risks.
- Power Solutions Allegations: Power Solutions is accused in a lawsuit covering May 2025 to March 2026 of overstating its ability to capture sales demand in the data center market and failing to adequately disclose the costs and inefficiencies related to manufacturing capacity enhancements, resulting in materially misleading positive statements.
- Hercules and Lufax Issues: Hercules Capital is alleged to have overstated its due diligence processes from May 2025 to February 2026, while Lufax faces legal challenges due to inadequate internal controls and materially misstated financial results, highlighting serious deficiencies in transparency and compliance within these companies.
See More
Multiple Companies Face Class Action Lawsuits
- Lufax Lawsuit Overview: Lufax Holding Ltd. faces a class action for the period from April 7, 2023, to January 26, 2025, due to undisclosed internal control deficiencies and misstated financial results, with a lead plaintiff deadline of May 20, 2026, potentially impacting the company's reputation and stock price.
- Atara Biotechnology Issues: Atara Biotherapeutics, Inc. is involved in a class action for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that overstated FDA approval prospects, with a lead plaintiff deadline of May 22, 2026, likely to have a significant negative impact on the company's financial condition.
- Coty Performance Decline: Coty Inc. is facing a class action for the period from November 5, 2025, to February 4, 2026, due to undisclosed underperformance in its Consumer Beauty segment and slowing market growth, with a lead plaintiff deadline of May 22, 2026, which may affect the company's future market performance.
- Legal Consultation Opportunity: Investors are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights and explore participation in these class actions, indicating that the legal risks faced by these companies could impact shareholder confidence and market performance.
See More
Lufax Faces Class Action Lawsuit Amid Significant Stock Drop
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Lufax, alleging securities fraud and other unlawful business practices by the company and certain officers, with investors urged to apply as Lead Plaintiff by May 20, 2026, highlighting serious governance concerns.
- Auditor Change Controversy: On January 27, 2025, Lufax proposed to replace its auditor, PricewaterhouseCoopers, due to significant concerns regarding the financial disclosures in its 2022 and 2023 Annual Reports, indicating a crisis in the company's financial transparency.
- Stock Price Volatility: Following the auditor change announcement, Lufax's American Depositary Shares fell nearly 22% over three trading sessions, a drastic decline that not only undermines investor confidence but may also negatively impact the company's future financing capabilities.
- Law Firm's Reputation: Pomerantz LLP is a prominent securities class action law firm with over 85 years of experience, focusing on advocating for victims of securities fraud, and its successful track record underscores its expertise and influence in the field.
See More
Reminder of Lufax Securities Class Action
- Class Action Notice: Rosen Law Firm reminds investors who purchased Lufax securities between April 7, 2023, and January 26, 2025, that they must apply to be lead plaintiff by May 20, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Lufax failed to disclose inadequate internal controls and materially misstated financial results during the class period, resulting in investor losses when the truth emerged, which negatively impacted the company's reputation and investor confidence.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, demonstrating its expertise and successful track record, thereby enhancing investor trust.
- Participation Instructions: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, ensuring they select qualified legal counsel to effectively protect their rights.
See More
Faruqi & Faruqi Investigates Potential Claims Against Lufax
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating potential claims against Lufax Holding Ltd., particularly for investors who purchased or acquired securities between April 7, 2023, and January 26, 2025.
- Investor Rights Reminder: The firm reminds investors that May 20, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, highlighting the urgency and potential legal ramifications of the case.
- Direct Contact Channels: Investors who have suffered losses are encouraged to contact Josh Wilson, a partner at Faruq & Faruqi, directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for consultation.
- Impact of Legal Action: This investigation may negatively affect Lufax's stock price and investor confidence, especially as the company faces a class action lawsuit, potentially leading to greater legal and financial risks.
See More
Lufax Securities Fraud Class Action Reminder
- Class Action Notice: Lufax (NYSE: LU) investors are reminded of an upcoming securities fraud class action lawsuit concerning shares purchased between April 7, 2023, and January 26, 2025, urging those who suffered losses during this period to take note of the impending legal action.
- Lawsuit Details: Filed in the U.S. District Court for the Central District of California, the lawsuit alleges that Lufax and certain senior officers violated the Securities Exchange Act of 1934, claiming that misrepresentations regarding the company's internal controls led to materially misstated financial results, potentially impacting investor recovery rights.
- Lead Plaintiff Requirements: Investors wishing to serve as lead plaintiffs must file necessary documents by May 20, 2026, with the lead plaintiff representing other class members in directing the litigation, while those opting not to participate can still share in any potential recovery.
- Legal Fee Structure: All representation is on a contingency fee basis, meaning shareholders incur no fees or expenses, which reduces the financial burden on investors and encourages more affected shareholders to take action.
See More
Multiple Companies Facing Class Action Lawsuits
- Class Action Overview: Gemini Space Station, Inc., Power Solutions International, Inc., Hercules Capital, Inc., and Lufax Holding Ltd. are all facing class action lawsuits from investors, emphasizing the urgency for investors to file lead plaintiff motions by the specified deadlines.
- Gemini Lawsuit Details: The lawsuit against Gemini alleges that from September 2025 to February 2026, the company overstated the viability of its core business as a crypto platform, leading to a significant overestimation of its post-IPO financial prospects and exposing it to potential costly and disruptive restructuring risks.
- Power Solutions Allegations: Power Solutions is accused in a lawsuit covering May 2025 to March 2026 of overstating its ability to capture sales demand in the data center market and failing to adequately disclose the costs and inefficiencies related to manufacturing capacity enhancements, resulting in materially misleading positive statements.
- Hercules and Lufax Issues: Hercules Capital is alleged to have overstated its due diligence processes from May 2025 to February 2026, while Lufax faces legal challenges due to inadequate internal controls and materially misstated financial results, highlighting serious deficiencies in transparency and compliance within these companies.
See More
Multiple Companies Face Class Action Lawsuits
- Lufax Lawsuit Overview: Lufax Holding Ltd. faces a class action for the period from April 7, 2023, to January 26, 2025, due to undisclosed internal control deficiencies and misstated financial results, with a lead plaintiff deadline of May 20, 2026, potentially impacting the company's reputation and stock price.
- Atara Biotechnology Issues: Atara Biotherapeutics, Inc. is involved in a class action for the period from May 20, 2024, to January 9, 2026, alleging undisclosed manufacturing issues and clinical trial risks that overstated FDA approval prospects, with a lead plaintiff deadline of May 22, 2026, likely to have a significant negative impact on the company's financial condition.
- Coty Performance Decline: Coty Inc. is facing a class action for the period from November 5, 2025, to February 4, 2026, due to undisclosed underperformance in its Consumer Beauty segment and slowing market growth, with a lead plaintiff deadline of May 22, 2026, which may affect the company's future market performance.
- Legal Consultation Opportunity: Investors are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights and explore participation in these class actions, indicating that the legal risks faced by these companies could impact shareholder confidence and market performance.
See More
